Evidence map›Paper›PMID 21877163›Full record

ArticleEuropean journal of epidemiology2011

The Rotterdam Study: 2012 objectives and design update.

Albert Hofman, Cornelia M van Duijn, Oscar H Franco, M Arfan Ikram, Harry L A Janssen, Caroline C W Klaver, Ernst J Kuipers, Tamar E C Nijsten, Bruno H Ch Stricker, Henning Tiemeier and 3 more

Abstract read
In one paragraph

Article in European journal of epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 26 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 26 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 26 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Albert HofmanDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. a.hofman@erasmusmc.nl
Cornelia M van Duijn
Oscar H Franco
M Arfan Ikram
Harry L A Janssen
Caroline C W Klaver
Ernst J Kuipers
Tamar E C Nijsten
Bruno H Ch Stricker
Henning Tiemeier
André G Uitterlinden
Meike W Vernooij
Jacqueline C M Witteman

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, oncological, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over a 1,000 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy ). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.

Indexed as

Epidemiologic Research DesignPopulation DynamicsAgedAged, 80 and overChronic DiseaseCohort StudiesFemaleHumansIncidenceLife ExpectancyMaleMiddle AgedNetherlandsRisk Assessment

Identifiers

PMID21877163
PMCPMC3168750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.